Price$417.54+4.75 (+1.15%)
01:30 PM07:30 PM
News · 26 weeks55-82%
2025-12-142026-06-07
Mix2990d
- Insider11(38%)
- Other7(24%)
- SEC Filings6(21%)
- Analyst3(10%)
- Earnings2(7%)
Latest news
25 items- PRElevance Health Expands Access to Digital Tools, Helping Bridge the Healthcare Digital DivideElevance Health is advancing its commitment to improving healthcare access by addressing one of healthcare's most pressing challenges: the digital divide. Through innovative programs like Get Connected for Health and services offered by CareBridge, a subsidiary of Elevance Health, the company is helping ensure that individuals - especially those in underserved communities - have the tools, connectivity, and support needed to help them better manage their healthcare. Access to digital health tools has become increasingly essential in today's healthcare environment. Yet millions of Americans still lack reliable internet access, appropriate devices, or the digital literacy required to fully
- INSIDERCAO & Controller Penczek Ronald W exercised 1,531 shares at a strike of $294.30 and sold $617,192 worth of shares (1,531 units at $403.13) (SEC Form 4)4 - Elevance Health, Inc. (0001156039) (Issuer)
- ANALYSTElevance Health upgraded by Deutsche Bank with a new price targetDeutsche Bank upgraded Elevance Health from Hold to Buy and set a new price target of $498.00
- INSIDERDirector Schulman Amy W was granted 563 shares, increasing direct ownership by 258% to 781 units (SEC Form 4)4 - Elevance Health, Inc. (0001156039) (Issuer)
- INSIDERDirector Schneider Ryan M. was granted 563 shares, increasing direct ownership by 9% to 7,163 units (SEC Form 4)4 - Elevance Health, Inc. (0001156039) (Issuer)
- INSIDERDirector Peru Ramiro G was granted 563 shares, increasing direct ownership by 6% to 9,908 units (SEC Form 4)4 - Elevance Health, Inc. (0001156039) (Issuer)
- INSIDERDirector Neri Antonio F was granted 563 shares, increasing direct ownership by 11% to 5,488 units (SEC Form 4)4 - Elevance Health, Inc. (0001156039) (Issuer)
- INSIDERDirector Jallal Bahija was granted 563 shares, increasing direct ownership by 12% to 5,351 units (SEC Form 4)4 - Elevance Health, Inc. (0001156039) (Issuer)
- INSIDERDirector Hay Lewis Iii was granted 563 shares, increasing direct ownership by 5% to 12,070 units (SEC Form 4)4 - Elevance Health, Inc. (0001156039) (Issuer)
- INSIDERDirector Dixon Robert L Jr was granted 563 shares, increasing direct ownership by 5% to 10,885 units (SEC Form 4)4 - Elevance Health, Inc. (0001156039) (Issuer)
- INSIDERDirector Devore Susan D. was granted 563 shares, increasing direct ownership by 16% to 4,065 units (SEC Form 4)4 - Elevance Health, Inc. (0001156039) (Issuer)
- INSIDERDirector Collis Steven H was granted 563 shares, increasing direct ownership by 15% to 4,202 units (SEC Form 4)4 - Elevance Health, Inc. (0001156039) (Issuer)
- SECElevance Health Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Elevance Health, Inc. (0001156039) (Filer)
- PRElevance Health Advances Efforts to Close Critical Gaps in Mental Health CareBy combining clinical programs, digital innovation and community partnerships, the company aims to improve wellbeing and reduce crises, ER visits and total cost of care for mental health Despite growing awareness, mental health concerns remain difficult to navigate and often lead to avoidable crises, costly emergency room visits, and long-term strain on individuals, families, and an already overburdened healthcare system. With nearly one in five Americans experiencing a diagnosable mental health condition each year, the need for funding and systemic improvement has never been greater. That's why Elevance Health is focused on addressing some of the most urgent challenges in mental health
- PRElevance Health Names Best in Class Primary Care Practices in Care Provider Recognition ProgramAnnual program honors practices delivering highest quality care and exceptional patient experience in Elevance Health's affiliated health plans across the country Elevance Health, along with its affiliated health plans, today announced 45 distinguished medical practices and health systems to be honored in its annual Care Provider Recognition Program. The program spotlights the top one percent of primary care providers in Elevance Health's nationwide affiliated health plan network of about 7,200 value-based care and evaluated provider partners. The recognition highlights primary care providers who exhibit excellence in delivering high-quality, coordinated care for members across Elevance
- PRElevance Health's Affiliated Health Plans Deliver More Predictable, Lower Healthcare Costs for Small BusinessesAs small businesses continue to face rising healthcare costs, Elevance Health's affiliated health plans are delivering solutions that help employers offer competitive benefits, improve health outcomes, and keep costs more affordable and more predictable. Recent research shows small businesses and their employees have experienced healthcare cost increases of 26% over the past five years, underscoring the need for more stable and predictable solutions. Small businesses are the backbone of the economy, yet they often lack the scale and flexibility larger employers have to manage healthcare expenses. Through innovative funding options like Balanced Funding* and Multiple Employer Welfare Arr
- ANALYSTElevance Health upgraded by BofA Securities with a new price targetBofA Securities upgraded Elevance Health from Neutral to Buy and set a new price target of $435.00
- SECSEC Form 10-Q filed by Elevance Health Inc.10-Q - Elevance Health, Inc. (0001156039) (Filer)
- SECElevance Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Elevance Health, Inc. (0001156039) (Filer)
- PRElevance Health Reports First Quarter 2026 Results; Raises Full-Year Guidance1Q 2026 operating revenue of $49.5 billion, up 1.5% from 1Q 2025 1Q 2026 diluted EPS1 of $8.00; adjusted diluted EPS2 of $12.58 driven by strong operating results and ~$1 per share of non-recurring investment income FY 2026 diluted EPS1 guidance to be at least $19.85, including the Company's estimate of the financial impact for the CMS matter FY 2026 adjusted diluted EPS2 guidance raised to at least $26.75, supported by underlying business strength, actions to reduce medical costs, and increased visibility Reaffirm FY 2026 operating cash flow of at least $5.5 billion, inclusive of potential cash payments for the CMS matter Returned $1.5 billion of capital to shareholders in
- ANALYSTEvercore ISI initiated coverage on Elevance Health with a new price targetEvercore ISI initiated coverage of Elevance Health with a rating of In-line and set a new price target of $345.00
- SECSEC Form PX14A6G filed by Elevance Health Inc.PX14A6G - Elevance Health, Inc. (0001156039) (Subject)
- PRElevance Health Announces Leadership Appointments to Strengthen Execution and Drive GrowthElevance Health, Inc. (NYSE:ELV) today announced a series of leadership appointments across its Health Benefits and Carelon organizations, positioning the company to strengthen execution, enhance operational performance, and drive continued growth across its businesses. These appointments support the continued expansion of Carelon, Elevance Health's services business, which provides a broad and expanding range of services across care, pharmacy, behavioral health, and data-driven insights to more than 90 million consumers across the healthcare system. As Carelon continues to scale, the updated leadership structure is designed to better align capabilities, accelerate decision-making, and
- PRElevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2026 Results on April 22, 2026Elevance Health (NYSE:ELV) will release first quarter 2026 financial results on April 22, 2026, at 6:00 a.m. Eastern Daylight Time ("EDT"). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 - Access Code - 3972058 (Domestic) 312-470-0178 - Access Code - 3972058 (International) 800-391-9853 - No Access Code (Domestic Replay) 203-369-3269 - No Access Code (International Replay) The call will be available through a live webcast at www.elevancehealth.com under the "Investors" link. You may also acces
- SECSEC Form DEFA14A filed by Elevance Health Inc.DEFA14A - Elevance Health, Inc. (0001156039) (Filer)
ELV FAQ
7 questionsWhat does Elevance Health Inc. do?
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.Where does ELV stock trade?
Elevance Health Inc. (ELV) is listed on NYSE.What sector and industry is ELV in?
Elevance Health Inc. operates in the Health Care sector, Medical Specialities industry.Does ELV pay a dividend?
Yes. ELV's next ex-dividend date is 2026-06-10 with a declared cash dividend of $1.72 per share, payable 2026-06-25.What are analysts saying about ELV?
Elevance Health Inc. has had 8 recent analyst actions on file. The most recent action was from Deutsche Bank: Buy on 2026-05-20.What companies are similar to ELV?
Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ANTM (Anthem Inc.), CI (The Cigna Group), HUM (Humana Inc.), NTRA (Natera Inc.). Compare ELV side-by-side with any of them on Quantisnow.How can I track ELV on Quantisnow?
Quantisnow aggregates Elevance Health Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ELV to receive live email and push alerts on every new disclosure.